GGrantIndex
Sort

53,477 grants matching addiction

Overcoming Tramadol Resistance In CYP2D6 Poor Metabolizers

$574,129
Stuart J Kahn · Syntrix Biosystems, Inc. · R44 · FY2012 · DA

Targeting Stromal Influences on BCKA Addiction in PDAC Tumors

$574,113
Deepak Nagrath · University Of Michigan At Ann Arbor · R01 · FY2025 · CA

Injury of blood brain and alveolar-endothelial barriers caused by alcohol and electronic cigarettes via purinergic receptor signaling

$574,030
Yuri Persidsky · Temple Univ Of The Commonwealth · R01 · FY2025 · AA

Prenatal & Environment Tobacco Smoke (ETS) Exposure: Effects on Child Regulation

$573,960
Rina D Eiden · State University Of New York At Buffalo · R01 · FY2008 · DA

Multi-Scale Imaging Core (MSIC)

$573,941
Hui-Chen Lu · Trustees Of Indiana University · P30 · FY2023 · DA

Harnessing telemedicine to improve alcohol use disorder outcomes in primary care patients

$573,935
Lewei Allison Lin · University Of Michigan At Ann Arbor · R01 · FY2025 · AA

Human Behavioral Pharmacology of Substance Abuse

$573,836
George Bigelow · Johns Hopkins University · T32 · FY2017 · DA

The neuroimmune model of excessive alcohol consumption: Transition to Alcohol Use Disorder.

$573,750
Igor Ponomarev · Texas Tech University Health Scis Center · R01 · FY2022 · AA

The neuroimmune model of excessive alcohol consumption: Transition to Alcohol Use Disorder.

$573,750
Igor Ponomarev · Texas Tech University Health Scis Center · R01 · FY2021 · AA

The neuroimmune model of excessive alcohol consumption: Transition to Alcohol Use Disorder.

$573,750
Igor Ponomarev · Texas Tech University Health Scis Center · R01 · FY2019 · AA

The neuroimmune model of excessive alcohol consumption: Transition to Alcohol Use Disorder.

$573,750
Igor Ponomarev · Texas Tech University Health Scis Center · R01 · FY2020 · AA

Inflammasome and unstable atherosclerotic plaques

$573,699
Ming-Hui Zou · Georgia State University · R01 · FY2019 · HL

An ethno-epidemiological study of the implementation and effectiveness of an innovative and comprehensive response to the evolving overdoseepidemic

$573,673
Thomas Kerr · University Of British Columbia · R01 · FY2023 · DA

Dual Processes in HIV Risk Behavior in Drug Abusers

$573,664
Alan W Stacy · Claremont Graduate University · R01 · FY2012 · DA

Neural Mechanisms of Individual Differences in Cocaine Avoidance

$573,638
Thomas C Chou · Medical University Of South Carolina · R37 · FY2021 · DA

Chronic Alcohol and Brain Stress Circuit Response

$573,638
Rajita Sinha · Yale University · R01 · FY2011 · AA

Substance Dependent Adolescents: Imaging Risk-Taking

$573,621
Thomas J Crowley · University Of Colorado Denver · R01 · FY2010 · DA

Integrated Stepped Care for Unhealthy Alcohol Use in HIV

$573,593
David Fiellin · Yale University · U01 · FY2013 · AA

Pharmacological Treatment of Cannabis Withdrawal and Dependence

$573,528
Barbara J Mason · Scripps Research Institute, The · R01 · FY2013 · DA

Biomarkers for predicting response to Hsp90 therapy

$573,509
Gabriela Chiosis · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA

Citicoline-Induced Modulation of Cannabis Effects: Imaging & Mechanism of Action

$573,506
Scott E Lukas · Mclean Hospital · R01 · FY2012 · DA

CRAFT for Parents of Adolescents in Outpatient Drug Treatment

$573,502
Kimberly C Kirby · Treatment Research Institute · P50 · FY2011 · DA

Brief Interventions for nicotine and cannabis use

$573,502
University Of Connecticut Sch Of Med/Dnt · R01 · FY2005 · DA

Brain Endophenotypes Modulating Drug Abuse Risk

$573,489
Robert A Zucker · University Of Michigan At Ann Arbor · R01 · FY2010 · DA

The Opioid mesolimbic system in heroin abuse

$573,487
Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · DA